GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $298,000 | +5.3% | 3,400 | +25.6% | 0.06% | +28.9% |
Q4 2019 | $283,000 | -40.3% | 2,708 | -34.2% | 0.04% | -45.8% |
Q3 2019 | $474,000 | +107.9% | 4,118 | +211.0% | 0.08% | +118.4% |
Q2 2019 | $228,000 | -54.4% | 1,324 | -67.9% | 0.04% | -67.5% |
Q1 2017 | $500,000 | – | 4,131 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |